Prague, Czech Republic
�
Zentiva Headquarters
Our
site
Zentiva’s Prague site is one of the company’s four production sites. It is located
in Dolní Měcholupy, in the southeastern part of the city. This multi-skill centre
employs approximately 900 qualified, dedicated staff of cultural diversity who
develop, produce, package and distribute high-quality medicines at affordable
prices, to patients in several different countries.
To achieve this, the site uses top-level industrial facilities with equipment supplied
from Western European countries. The manufacturing site is thus dedicated to
producing active ingredients, manufacturing finished products, packaging and
distributing high-quality medicines.
This is an important site for Sanofi and is managed by Ivan Hondré.
Key Facts
and Figures
The site
Ivan Hondré, Site Director
●
●
●
●
●
●
Covers 14 hectares and includes Zentiva’s head office
Has over 30 buildings
Manufactures 120 million units/year
Employs approx. 900 employees, 200 of whom work in development
Employs staff with nine different nationalities
Actively collaborates with universities around Europe
Main products manufactured at the site: Agen® (amlodipine), B-Komplex® (Vitamin B1&B12), Coxtral® (Nimesulide),
Ibalgin® (ibuprofen), Paralen® (paracetamol)
and Simvacard® (simvastatin)
Our Development
Zentiva’s Prague site has a fully integrated development centre with
approx. 200 employees. The award-winning centre pioneers the entire
development process from API to final formulation. It also provides
support to Zentiva’s other development centres, to universities and to
many of Sanofi´s sites. For the past two years, the Prague development
centre has won Industrial Innovation awards in Sanofi´s annual
competition.
REGULATORY STATUS
Zentiva’s Prague site has a manufacturing certificate from the Czech
Republic’s State Institute of Drug Control (SUKL) and GMP certificates
(Good Manufacturing Practices) confirming the site’s compliance
with European GMP requirements. In 2011, the site was successfully
inspected by the United States Food and Drug Administration for
manufacturing active pharmaceutical ingredients.
MANUFACTURING HISTORY
Zentiva has a long history of producing high-quality pharmaceuticals.
Today, it is the third-largest and fastest-growing generics company
in Europe, having transformed itself from a small pharmacy in Prague.
Throughout its remarkable history, Zentiva has maintained a highly
successful business that continues to deliver modern, affordable and
quality medicines that meet the needs of many patients in several
countries.
15th century
Zentiva’s origins traced back to the “Black Eagle” pharmacy in Prague.
1857
“Black Eagle” pharmacy purchased by the Fragner family.
1930
The company starts production in Dolní Mĕcholupy.
1946
The company is nationalised by the Czech government.
The plant at Dolní Měcholupy becomes a leader
in pharmaceutical production in Czechoslovakia.
1998
Management buyout of the company starts a new phase in the company’s
development as it focuses on branded generics. Investments are
made in state-of-the-art facilities and R&D.
2009
Zentiva becomes part of Sanofi and an important part
of its strategy to become a diversified global healthcare
company focused on patiens’ needs.
Teplice
D6 E55
Mladá Boleslav
10 E65
Slaný
7
Poděbrady
D11 E67
Karlovy Vary
6 E48
Plzeň
D5 E50
Brno
How to reach us
FROM THE AIRPORT:
The easiest way to reach Zentiva’s offices is to take
a taxi from Ruzyně airport. The 34 km journey takes
30–45 minutes, depending on traffic.
BY CAR:
Zentiva’s headquarters are in Dolní Mĕcholupy, located
in the southeast of the city. It is ideally served by both
the E50 and E65 highways, situated near Hostivař.
There are parking facilities for 22 cars.
BY PUBLIC TRANSPORT:
There are several buses and trams available from
the city centre.
OUR ADDRESS:
Zentiva, k.s.
U Kabelovny 130
102 37, Prague 10
Czech Republic
Tel +420 267 241 111, Fax +420 272 702 402
www.zentiva.com
D1
E50 E55 E65
Příbram
4